It would be also interesting to synthesize and develop pharmacological compounds that target TRPV1, TRPV2, and TRPA1 that were shown to be downregulated in some types of cancers and whose activity enhances differentiation and impairs stemness. This evidence concerns the gene TRPV1 and cancer.